IL165716A0 - Pharmaceutical compositions containing heterocyclic adenosine receptor antagonists - Google Patents

Pharmaceutical compositions containing heterocyclic adenosine receptor antagonists

Info

Publication number
IL165716A0
IL165716A0 IL16571604A IL16571604A IL165716A0 IL 165716 A0 IL165716 A0 IL 165716A0 IL 16571604 A IL16571604 A IL 16571604A IL 16571604 A IL16571604 A IL 16571604A IL 165716 A0 IL165716 A0 IL 165716A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
receptor antagonists
containing heterocyclic
adenosine receptor
Prior art date
Application number
IL16571604A
Original Assignee
Mcw Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/018695 external-priority patent/WO2003105666A2/en
Application filed by Mcw Res Found Inc filed Critical Mcw Res Found Inc
Publication of IL165716A0 publication Critical patent/IL165716A0/en

Links

IL16571604A 2003-06-12 2004-12-12 Pharmaceutical compositions containing heterocyclic adenosine receptor antagonists IL165716A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/018695 WO2003105666A2 (en) 2002-06-12 2003-06-12 Method of treating ischemia reperfusion injury using adenosine receptor antagonists
US38868004P 2004-06-12 2004-06-12

Publications (1)

Publication Number Publication Date
IL165716A0 true IL165716A0 (en) 2006-01-15

Family

ID=37215759

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16571604A IL165716A0 (en) 2003-06-12 2004-12-12 Pharmaceutical compositions containing heterocyclic adenosine receptor antagonists

Country Status (1)

Country Link
IL (1) IL165716A0 (en)

Similar Documents

Publication Publication Date Title
HUS1700044I1 (en) (thio)carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
AP1828A (en) Muscarinic Acetycholine receptor antagonists
HK1073304A1 (en) Triazole derivatives as tachykinin receptor antagonists
HK1090922A1 (en) Cgrp receptor antagonists cgrp
IL174909A0 (en) Pharmaceutical compositions containing an interleukin-6 antagonist
IL176122A0 (en) Pharmaceutical compositions containing an interleukin-6 antagonist
IL169575A0 (en) Calcium-sensing receptor antagonist compounds and pharmaceutical compositions containing the same
IL175759A0 (en) A2b adenosine receptor antagonists
IL177902A0 (en) Pharmaceutical compositions containing an interleukin-6 antagonist
EP1758458A4 (en) Compositions containing opioid antagonists
IL172822A0 (en) Muscarnic acetylcholine receptor antagonists
IL171930A0 (en) Imidazole derivatives as glutamate receptor antagonists
EP1808446A4 (en) Il-18 receptor antagonist and pharmaceutical composition containing the antagonist
IL178622A0 (en) Piperazinylpiperidine derivatives as chemokine receptor antagonists
PL377053A1 (en) 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
IL160715A0 (en) Pharmaceutical compositions containing an a1 adenosine receptor antagonist
AU2002356369A1 (en) Xanthine derivatives as muscarinic receptor antagonists
IL157398A0 (en) Pharmaceutical compositions comprising ccr5 antagonists
SG131946A1 (en) Ccr3 receptor antagonists
EP1636230A4 (en) A1 adenosine receptor antagonists
IL165716A0 (en) Pharmaceutical compositions containing heterocyclic adenosine receptor antagonists
IL160438A0 (en) Pharmaceutical compositions containing an angiotensin ii receptor antagonist
GB0302094D0 (en) EP4 receptor antagonists
HU0400845D0 (en) Pharmaceutical composition containing vanilloid receptor antagonist
ZA200608369B (en) Piperazinylpiperidine derivatives as chemokine receptor antagonists